On (b)(6) 2022, neotract was made aware of a patient who received and successful prostatic urethral lift (pul) procedure on an unspecified date.It was reported that the patient was taking blood thinning medication, but had discontinued use during an unspecified time period for the pul procedure.The patient was advised by his cardiologist to resume the blood thinner sooner than desired by the physician who performed the procedure.As a result, the patient experienced excessive bleeding and an embolism, and was admitted to the hospital for three weeks post procedure.No further information is available for this patient despite multiple attempts contact the physician.
|